À retenir
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
Study design
Essai randomisé
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Observational cohort studies and a secondary prevention trial (in people who already had cardiovascular disease) had linked closer adherence to a Mediterranean diet with lower cardiovascular risk. This trial asked whether a Mediterranean diet supplemented with extra-virgin olive oil, or with mixed nuts, prevents a first major cardiovascular event better than advice to reduce dietary fat. It is also a republication: after the 2013 report, the authors found protocol deviations in how participants were assigned, withdrew that paper and reanalysed the data.
Population et méthode
This was a multicentre trial in Spain. It assigned 7447 participants aged 55 to 80 years (57% women) who were at high cardiovascular risk but had no cardiovascular disease at enrolment to one of three diets: a Mediterranean diet supplemented with extra-virgin olive oil, a Mediterranean diet supplemented with mixed nuts, or a control diet consisting of advice to reduce dietary fat. All participants attended quarterly educational sessions. Depending on group, they were also given free extra-virgin olive oil, free mixed nuts, or small nonfood gifts. Full details are not in the abstract, so how participants were recruited, how closely they followed the diets and what the 'high risk' criteria were are not described here.
The primary end point was a major cardiovascular event: myocardial infarction (heart attack), stroke, or death from cardiovascular causes. After a median follow-up of 4.8 years the trial was stopped on the basis of a prespecified interim analysis. Afterwards the authors identified protocol deviations: household members enrolled without randomisation, some participants at 1 of 11 study sites assigned to a group without randomisation, and apparently inconsistent use of randomisation tables at another site. They withdrew the 2013 report and now give revised estimates from analyses that do not rely exclusively on the assumption that everyone was randomly assigned. The main analysis was by intention to treat in all participants, adjusted for baseline characteristics and propensity scores (a statistical way of balancing the groups on measured traits).
Résultats
- 1A primary end-point event occurred in 288 participants, more often in the control group than in either Mediterranean group: 96 events (3.8%) with olive oil, 83 (3.4%) with nuts and 109 (4.4%) with the control diet.
- 2After adjustment for baseline characteristics and propensity scores, the hazard ratio versus the control diet was 0.69 (95% CI 0.53 to 0.91) for the Mediterranean diet with extra-virgin olive oil and 0.72 (95% CI 0.54 to 0.95) for the Mediterranean diet with nuts.
- 3The result held up when the authors left out 1588 participants whose group assignments were known or suspected to have departed from the protocol; the abstract says the estimates were similar.
- 4The percentages above are the crude share of each group with an event, while the hazard ratios are relative measures that account for follow-up time and adjustment. The abstract does not give separate estimates for heart attack, stroke or cardiovascular death.
- 5The authors conclude that major cardiovascular events were less frequent with a Mediterranean diet supplemented with extra-virgin olive oil or nuts than with a reduced-fat diet. The trial was stopped early at a prespecified interim analysis, after a median follow-up of 4.8 years.
Limites et incertitude
- 1The authors note protocol deviations: household members were enrolled without randomisation, some participants at 1 of 11 sites were assigned without randomisation, and randomisation tables were apparently used inconsistently at another site. The revised analyses therefore cannot lean only on randomisation to rule out differences between the groups.
- 2Propensity-score adjustment can only balance traits that were measured. Unmeasured differences between groups cannot be corrected this way, and the abstract does not say how many people were affected beyond the 1588 whose assignment was known or suspected to have departed from the protocol.
- 3Our observation: the intervention was a package of free olive oil or nuts, a Mediterranean diet and quarterly teaching, compared with advice to cut dietary fat plus small nonfood gifts. The trial cannot tell which part, or which single food, produced the difference, and the comparison is with a reduced-fat diet, not with usual eating.
- 4Our observation: the participants were Spanish adults aged 55 to 80 who were at high cardiovascular risk and free of cardiovascular disease, and follow-up was a median of 4.8 years. The lower limits of the confidence intervals sit close to 1 (0.91 and 0.95), and a trial stopped at an interim analysis can overstate benefit, so the size of the effect is uncertain.
Mise en perspective
For older adults at high cardiovascular risk, this trial supports an overall Mediterranean eating pattern, built around extra-virgin olive oil or nuts, as a way to lower the chance of a first heart attack, stroke or cardiovascular death compared with a reduced-fat diet. The tested intervention was a whole eating pattern with regular teaching and free supplies, so adding oil or nuts to an otherwise unchanged diet is not what was tested.
It does not show that a single food prevents heart disease, that the same effect applies to younger or lower-risk people, or that diet can replace medicines a clinician has prescribed. Confidence is moderate: the effect looks consistent across both Mediterranean groups and after exclusions, but the randomisation problems and the early stop mean the size of the benefit should be held loosely. Decisions about heart-disease prevention belong with a clinician.
Vos données
A wearable cannot measure the end points of this trial, and you should not expect an immediate change in a daily score. What you can record is the eating pattern itself in a food log, such as olive oil, nuts and overall meal quality, alongside blood pressure from a cuff taken at the same time of day and weight trends over months. Lipid and glucose results from your clinician's tests are the better markers to compare year on year, with your medicines and any other changes noted.
Comprendre ce type de preuve
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Sources et attribution
Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts
The New England Journal of Medicine · 2018-06-21
DOI: 10.1056/NEJMoa1800389 ↗PubMed · 29897866 ↗Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Low-fat vs low-carb: similar weight loss at 12 months, and no genotype or insulin match
In 609 adults without diabetes, 12-month weight change was -5.3 kg on a healthy low-fat diet and -6.0 kg on a healthy low-carbohydrate diet, a 0.7 kg gap (95% CI -0.2 to 1.6 kg) that was not statistically significant. A tested genotype pattern and baseline insulin secretion did not predict who did better on which diet. Both arms received 22 coaching sessions and 79% finished, so this describes coached dieting in adults aged 18 to 50.
JAMA

